Lotte Biologics completes acquisition of Bristol Myers Squibb plant in Syracuse

Lotte Biologics completed the acquisition of a plant from Bristol Myers Squibb in Syracuse, New York for $160 million on January 1, 2023, to develop it as its North American center.

“Lotte Biologics completed the acquisition of a plant from global biopharmaceutical company Bristol Myers Squibb in Syracuse, New York for $160 million on Jan. 1”pulse.mk.co.kr

• 1 source
• pulse.mk.co.krLotte Biologics to invest $3 bn to build 3 plants by 2030 - 매일경제 영문뉴스 펄스(Pulse)Jan 11, 2023

Summarized from public sources; check the original articles before acting on it.